Allergan to Hold Special Meeting of Stockholders On Originally Scheduled Date of Dec. 18 Without Restriction

By Staff
Friday, September 19, 2014 12:26 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) announced that it has reached an agreement with Pershing Square Capital Management, L.P. and Valeant Pharmaceuticals (NYSE: VRX) under which Allergan will hold the Special Meeting of Stockholders on the originally scheduled date of Dec.18, 2014, without restriction, and Pershing Square and Valeant will dismiss their pending litigation before the Delaware Court of Chancery.

Allergan Provides Update on Written Requests from Pershing Square Regarding Special Meeting

By Staff
Monday, September 08, 2014 12:26 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) provided an update regarding the validity of the written requests from Allergan stockholders that were delivered by Pershing Square Capital Management, L.P. to request a Special Meeting of Stockholders.

The Cooper Companies Report Second Quarter Results

By Staff
Friday, September 05, 2014 12:23 AM PLEASANTON, Calif.— The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal second quarter ended April 30, 2014.

Essilor’s Revenue Rises in First-Half 2014

By Staff
Friday, August 29, 2014 12:23 AM CHARENTON-LE-PONT, France— Essilor International (Reuters: ESSI.PA) yesterday posted revenue of €2.78 billion for the six months ended June 30, 2014, up 7.9 percent from €2.58 billion in the first half of 2013.

New Look Eyewear Inc. Closes $10 Million Private Placement

By Staff
Wednesday, August 20, 2014 12:23 AM MONTREAL— New Look Eyewear Inc. (BCI) said yesterday that it has completed its previously announced "bought deal" private placement subscription receipt financing for aggregate gross proceeds of $10 million, in connection with the offering to fund the recently-announced acquisition of certain assets and business of the Grieche & Scaff banner here, as reported earlier this month by VMail.

InSite Vision Inc. Reports Q2 2014 Results

By Staff
Friday, August 15, 2014 12:23 AM ALAMEDA, Calif.— InSite Vision Incorporated (OTCBB:INSV) has reported financial results for the second quarter ended June 30, 2014.

Allergan and Valeant Pharmaceuticals Receive FTC Second Request Under Hart-Scott-Rodino Act

By Staff
Wednesday, August 13, 2014 12:16 AM IRVINE, Calif. And Quebec— Allergan, Inc. (NYSE: AGN) and Valeant Pharmaceuticals (NYSE:VRX)  have both received a request for additional information (a "Second Request") under the Hart-Scott-Rodino Act from the U.S. Federal Trade Commission in connection with Valeant’s unsolicited acquisition proposal of Allergan.

Spy Reports First Half and Q2 2014 Results

By Staff
Friday, August 08, 2014 12:26 AM CARLSBAD, Calif.— SPY Inc. (OTCBB: XSPY) has announced its financial results for the second quarter and first six months ended June 30, 2014.

New Look Eyewear Reports Record Sales for Q2 and First Half

By Staff
Friday, August 08, 2014 12:23 AM MONTREAL— New Look Eyewear Inc. (TSX: BCI) announced its results for the second quarter, for the period ending June 28, 2014 and reported record revenues of $35.1 million for the period.

Allergan Sues Valeant and Pershing Square

By Staff
Friday, August 01, 2014 2:00 PM IRVINE, Calif.— Valeant and Pershing Square Capital Management’s $51 billion hostile takeover bid for Allergan is taking a new turn with Allergan filing a lawsuit alleging that Valeant, Pershing Square and its principal, William A. Ackman, violated federal laws prohibiting insider trading.

Safilo Approves Q2 and First Half 2014 Financial Results

By Staff
Friday, August 01, 2014 12:23 AM PADUA—The Board of Directors of Safilo Group S.p.A. (SFL:MI) has approved today the results of the second quarter and first half of 2014, ended June 30.

Valeant Pharmaceuticals Reports Revenue Increase for Q2

By Staff
Friday, August 01, 2014 12:21 AM LAVAL, Quebec – Valeant Pharmaceuticals, Inc. (NYSE/TSX:VRX) reported its total revenue for the second fiscal quarter was $2.0 billion, up 86 percent compared to the second quarter of 2013, driven by strong growth in almost all of its businesses, the company said.

SynergEyes Raises $12 Million in New Financing

By Staff
Friday, August 01, 2014 12:20 AM CARLSBAD, Calif. – SynergEyes, Inc., manufacturer and marketer of the Duette and UltraHealth families of contact lenses, announced it has raised $12 million to accelerate expansion of its contact lenses for patients with astigmatism, presbyopia and irregular corneas.

Luxottica Group Q2 2014 Results Show Continuing Growth in North America, Emerging Markets and Europe

By Staff
Friday, July 25, 2014 12:26 AM
MILAN— Luxottica Group (NYSE: LUX) reported accelerated net sales growth in the second quarter ending June 30, 2014 to €2,060 million, up 7 percent at constant exchange rates when compared to the €2,018 million generated during the same period of 2013, according to the company’s financial results released yesterday.

Allergan Sales Rose Nearly 16 Percent in Second Quarter

By Staff
Wednesday, July 23, 2014 12:26 AM IRVINE, Calif.— Allergan (NYSE: AGN) reported $1,827.3 million total product net sales for the quarter ended June 30, 2014, a 15.9 percent compared to total product net sales in the second quarter of 2013.
Loading...